Velocity Clinical Research, New Smyrna Beach is a clinical research site located in Edgewater, Florida, United States 32132.
Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.
Velocity Clinical Research, New Smyrna Beach has participated in 9 clinical trials with 2 currently active.
Therapeutic areas: Renal Insufficiency, Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps, Chronic Hepatitis D Infection.
Sponsors: Eli Lilly and Company, Pfizer, Gilead Sciences.
Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Velocity Clinical Research, New Smyrna Beach has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Velocity Clinical Research, New Smyrna Beach has 9 clinical trials on record, with 2 currently active. Their work covers Renal Insufficiency, Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps, Chronic Hepatitis D Infection.
Yes — Velocity Clinical Research, New Smyrna Beach holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.